AngioDynamics, Inc. (ANGO)
NASDAQ: ANGO · Real-Time Price · USD
11.00
-0.10 (-0.86%)
Apr 28, 2026, 4:00 PM EDT - Market closed
AngioDynamics Revenue
AngioDynamics had revenue of $78.42M in the quarter ending February 28, 2026, with 8.91% growth. This brings the company's revenue in the last twelve months to $313.73M, up 10.73% year-over-year. In the fiscal year ending May 31, 2025, AngioDynamics had annual revenue of $292.50M, down -3.76%.
Revenue (ttm)
$313.73M
Revenue Growth
+10.73%
P/S Ratio
1.47
Revenue / Employee
$464,778
Employees
675
Market Cap
458.29M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2025 | 292.50M | -11.42M | -3.76% |
| May 31, 2024 | 303.91M | -34.84M | -10.28% |
| May 31, 2023 | 338.75M | 22.53M | 7.13% |
| May 31, 2022 | 316.22M | 25.21M | 8.66% |
| May 31, 2021 | 291.01M | 26.85M | 10.17% |
| May 31, 2020 | Pro | Pro | Pro |
| May 31, 2019 | Pro | Pro | Pro |
| May 31, 2018 | Pro | Pro | Pro |
| May 31, 2017 | Pro | Pro | Pro |
| May 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Embecta | 1.08B |
| Azenta | 595.03M |
| OraSure Technologies | 115.02M |
| Sanara MedTech | 103.12M |
| BioLife Solutions | 96.21M |
| KORU Medical Systems | 41.13M |
| Utah Medical Products | 37.53M |
| Stereotaxis | 32.38M |
ANGO News
- 14 days ago - AngioDynamics Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 26 days ago - AngioDynamics Earnings Call Transcript: Q3 2026 - Transcripts
- 26 days ago - AngioDynamics Reports Fiscal Year 2026 Third Quarter Financial Results; Sustained Double-Digit Med Tech Growth Drives Continued Profitability - Business Wire
- 4 weeks ago - AngioDynamics to Present at the 25th Annual Needham Virtual Healthcare Conference - Business Wire
- 5 weeks ago - AngioDynamics to Report Fiscal 2026 Third Quarter Results on April 2, 2026 - Business Wire
- 7 weeks ago - AngioDynamics Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 2 months ago - AngioDynamics to Present at the Leerink Partners Global Healthcare Conference - Business Wire
- 2 months ago - AngioDynamics Expands Indications for the NanoKnife System Across Europe, Strengthening Multi-Organ Tumor Ablation Platform - Business Wire